Pioneering the Future of Healthcare
At MQuadruple, we are dedicated to revolutionizing healthcare through innovative biosensing technology and diagnostic solutions. Our commitment to excellence in research and development drives us to create cutting-edge solutions that address global health challenges.
Our Lab in Action
Watch our state-of-the-art laboratory facilities and witness our groundbreaking research in progress.
Our Mission
We strive to advance global healthcare through groundbreaking research in biosensing technology and diagnostic solutions. Our focus on innovative approaches to medical diagnostics, particularly in infectious diseases, positions us at the forefront of healthcare technology advancement.
Meet Our Founder
Dr Adewoyin M. Ogunmolasuyi is an emerging African researcher with global ambitions to deliver innovations in medical diagnostics, using novel biomedical engineering, including expertise in microfluidics and biosensing.
He joined Professor Janice Laboratory (BioSens Research Group) at the Biotechnology Innovation Centre (BIC), Rhodes University (RU), South Africa, with a scholarship from Tertiary Education Trust Fund (TETFUND), Nigeria and United Nation Children Emergency Fund (UNICEF) to finance his doctoral studies between 2017 and 2020.
During his doctoral studies, he constructed a microfluidic paper analytical device (μPAD) of similar geometry to lateral flow device to deliver an aptamer-tethered enzyme capture (APTEC) and enzyme-linked oligonucleotide assays for detection of Plasmodium falciparum lactate dehydrogenase in malaria. In addition, he employed several electrochemical biosensor designs such as electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), chronoamperometry to establish different innovative bio-conjugation chemistries (e.g. carbodiimide, avidin-biotin, thiol-gold contact etc) that are required for effective biosensing phenomena. His PhD research achievements added significant value to BioSens Research Group enabling UNICEF to launch a new research laboratory in December, 2019.
Following his PhD, he was awarded research grant ($29689) internationally by USAID through African Research Network for Neglected Tropical Diseases (ARNTD) in 2020 to develop low-cost, low-power point-of-care diagnostic tests, based on novel paper microfluidic technology (engineering), coupled with new biomolecular sensing constructs (aptamer) for schistosomiasis. This platform technology is able to unlock a wide range of applications and he is currently focussed on integrating malaria and schistosomiasis into a multiplexed detection system to address coinfection of both diseases where they are prevalent in Africa and globally.
Dr Ogunmolasuyi has developed and sustained an international consortium involving University of Glasgow (Prof. Julien Reboud, UK), Rhodes University (Janice Limson, South Africa) with networks of collaborators in Nigeria. He has published first-author peer-reviewed papers in renowned journals from his past research activities and attended several local and international conferences.
